Dementia Clinical Trials

A listing of Dementia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35294

A clinical trial seeking patients for a research study for the treatment of Dementia With Lewy Bodies or REM Sleep Behavior Disorder

Birmingham Alabama 35294

A clinical trial to evaluate treatments using SYN120 and Placebo for patients with Parkinson's Disease Dementia (PDD)

Arizona

Xenoscience
Phoenix Arizona 85004

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Territory Neurology & Research Institute
Tucson Arizona 85704

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

View More ▼

Phoenix Arizona 85032

A clinical research study of AVP-786 and Placebo for the treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Phoenix Arizona 85013

A clinical trial to evaluate treatments using RVT-101 35 mg and Placebo for patients with Alzheimer's Disease, Dementia With Lewy Bodies or Parkinson's Disease Dementia

UPDATED

Phoenix Arizona 85013

A Phase 2 clinical study for patients with Dementia With Lewy Bodies, The HEADWAY-DLB Study

UPDATED

Phoenix Arizona 85006

A Phase 2 clinical study for patients with Dementia With Lewy Bodies, The HEADWAY-DLB Study

UPDATED

Phoenix Arizona 85013

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

UPDATED

Phoenix Arizona 85006

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

UPDATED

Phoenix Arizona 85004

A Phase 3 clinical study for patients with Alzheimer's Disease

Phoenix Arizona

Patients are needed to participate in a clinical research study evaluating AVP-786 for the treatment of Agitation in Alzheimer's Disease

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study of AVP-786 and Placebo to evaluate Agitation in Patients With Dementia of the Alzheimer's Type

UPDATED

Scottsdale Arizona 85260

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Scottsdale Arizona 85258

A Phase 3 clinical study for patients with Alzheimer's Disease

Sun City Arizona 85351

A clinical trial to evaluate treatments using SYN120 and Placebo for patients with Parkinson's Disease Dementia (PDD)

UPDATED

Sun City Arizona 85351

A Phase 2 clinical study for patients with Dementia With Lewy Bodies, The HEADWAY-DLB Study

UPDATED

Sun City Arizona 85351

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

Sun City Arizona

Patients are needed to participate in a clinical research study of ITI-007 and Placebo to evaluate Agitation in Dementia, Including Alzheimer's Disease

UPDATED

Tucson Arizona 85704

A Phase 2 clinical study for patients with Dementia With Lewy Bodies, The HEADWAY-DLB Study

UPDATED

Tucson Arizona 85704

A Phase 2/Phase 3 clinical study for patients with Alzheimer´s Disease

UPDATED

Tucson Arizona 85718

A Phase 3 clinical study for patients with Alzheimer's Disease

Arkansas

Fayetteville Arkansas

Patients are needed to participate in a clinical research study evaluating AVP-786 for the treatment of Agitation in Alzheimer's Disease

Fayetteville Arkansas 72703

Patients are needed to participate in a clinical research study of AVP-786 and Placebo to evaluate Agitation in Patients With Dementia of the Alzheimer's Type

UPDATED

Jonesboro Arkansas 72401

A Phase 3 clinical study for patients with Alzheimer's Disease

Little Rock Arkansas

Patients are needed to participate in a clinical research study of ITI-007 and Placebo to evaluate Agitation in Dementia, Including Alzheimer's Disease

Rogers Arkansas

Patients are needed to participate in a clinical research study of ITI-007 and Placebo to evaluate Agitation in Dementia, Including Alzheimer's Disease

View More ▼

UPDATED

Springdale Arkansas 72764

A Phase 3 clinical study for patients with Alzheimer's Disease

California

Research Center
Additional Locations California

Clinical Research for Patient with Mild Cognitive Impairment due to Alzheimer's Disease or Mild to Moderate Alzheimer’s Disease disease

Pharmacology Research Institute, Encino
Encino California 91316

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study Of Crenezumab In Patients With Prodromal To Mild Alzheimer’s Disease

Alliance Research Center
Laguna Hills California 92653

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Renew Behavioral Health, Inc.
Long Beach California 90807

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Pharmacology Research Institute, Los Alamitos
Los Alamitos California 90720

A 24-month, multi-center, double-blind, randomized, placebo-controlled Medical food study for the efficacy of Vayacog® in Mild Cognitive Impairment (MCI), "PROTECT"

Pharmacology Research Institute, Los Alamitos
Los Alamitos California 90720

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study Of Crenezumab In Patients With Prodromal To Mild Alzheimer’s Disease

Pharmacology Research Institute, Newport Beach
Newport Beach California 92660

A 24-month, multi-center, double-blind, randomized, placebo-controlled Medical food study for the efficacy of Vayacog® in Mild Cognitive Impairment (MCI), "PROTECT"

Pharmacology Research Institute, Newport Beach
Newport Beach California 92660

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy And Safety Study Of Crenezumab In Patients With Prodromal To Mild Alzheimer’s Disease

Excell Research, Inc.
Oceanside California 92056

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Asclepes Research Center
Panorama City California 91402

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Northern California Research
Sacramento California 95821

Cognite Trial – A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals with Evidence of Early Alzheimer’s Disease

Northern California Research
Sacramento California 95821

Patients with Mild-Moderate Alzheimer's Disease

Sharp Mesa Vista Hospital Clinical Research Center
San Diego California 92123

This study is a Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease.

Schuster Medical Research Institute
Sherman Oaks California 91403

A Phase III, Randomized, Placebo-Controlled, Double Blind Clinical Trial to study the Efficacy and Safety of MK-8931 in Subjects with Amnestic Mild Cognitive Impairment (aMCI) due to Alzheimer’s Disease (prodromal AD).

View More ▼

UPDATED

Anaheim California 92805

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Carlsbad California 92011

A Phase 3 clinical study for patients with Alzheimer's Disease

UPDATED

Costa Mesa California 92626

A Phase 3 clinical study for patients with Alzheimer's Disease

Costa Mesa California

Patients are needed to participate in a clinical research study of elenbecestat and Placebo to evaluate Alzheimer's Disease

Costa Mesa California

Patients are needed to participate in a clinical research study of ITI-007 and Placebo to evaluate Agitation in Dementia, Including Alzheimer's Disease

Fountain Valley California 92708

A clinical trial seeking patients for a research study for the treatment of Dementia With Lewy Bodies or REM Sleep Behavior Disorder

Fountain Valley California 92708

A Phase 2 clinical study for patients with Lewy Body Dementia or Visual Hallucinations